{
    "code": 0,
    "data": [
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Nine Month Ended December 31 2025.",
            "news_body": "Please find attached herewith Results For Quarter And Nine months Ended December 31 2025.",
            "news_id": "c57b5788-0535-4f80-928e-1975a76fa058",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d21bf44-3bb8-41cb-9d2c-d8b5dab33541.pdf",
            "news_date": "2026-01-23 16:48:22",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30 2025.",
            "news_body": "Please find attached herewith Results For Quarter And Half Year Ended September 30 2025.",
            "news_id": "cabd6623-f14a-4df0-a6d5-ad7504ef0331",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66d0bb8-3b1f-48a2-99b3-72bf4074ac67.pdf",
            "news_date": "2025-11-14 17:45:08",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Please find attached herewith the financial results for the quarter ended on June 30 2025.",
            "news_id": "971f8301-5024-4ac4-9adf-f68b8a51521f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b325528-e81b-44a6-8266-33263d252324.pdf",
            "news_date": "2025-08-14 16:52:35",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year 2024-25",
            "news_body": "Financial Results for the Year 2024-25",
            "news_id": "e20d6a69-ea46-466e-b6c5-c98c3a21a908",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44994666-116a-4472-9579-afd6c201ce29.pdf",
            "news_date": "2025-07-07 23:26:35",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Delay in Financial Results",
            "news_body": "Please find attached herewith the reason for delay in financial results for the quarter and year ended on March 31 2025.",
            "news_id": "d5dceb88-d079-404c-a2ba-b8ff68e25ee5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37d9a35e-ab28-4b02-9614-ca6f9178b1d3.pdf",
            "news_date": "2025-05-30 16:27:57",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation based on Q325 performance",
            "news_id": "af26d2a7-a37a-4715-a2b7-20623d1315a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44dc5b24-6ff3-40c3-b404-045f4e272b3d.pdf",
            "news_date": "2025-01-31 20:50:12",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Period Ended On December 31 2024.",
            "news_body": "Please find attached herewith Unaudited Financial Results for period ended on December 31 2024.",
            "news_id": "d4109ec6-ed92-4f19-a492-4dbf349e9434",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe447b15-3e52-4067-83c2-0f5136c62a1a.pdf",
            "news_date": "2025-01-31 17:17:48",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "4210bd82-bbbd-4250-9e12-e5da3a342b93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e48f5cf-e5fc-49ca-9e41-c6e426e623cc.pdf",
            "news_date": "2024-11-14 14:06:32",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30, 2024.",
            "news_body": "Results for quarter and half year ended September 30, 2024.",
            "news_id": "74f6cf9e-230d-41b4-b9a0-a37153967624",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22104ccf-136d-45a5-a3f8-a26b7a34f024.pdf",
            "news_date": "2024-11-14 13:47:35",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30, 2024",
            "news_body": "Please find attached herewith the financial results for the quarter ended on June 30, 2024",
            "news_id": "dc446287-600e-401f-9f4e-6450c704a682",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad64ca77-b42a-405d-9e18-db0bb1b53746.pdf",
            "news_date": "2024-08-14 13:26:20",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Outcome Of Board Of Directors' Meeting",
            "news_body": "Audited Financial Results and outcome of Board Meeting",
            "news_id": "2b825c4d-3c1b-4d32-bc5d-e5314d1453d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a27d850e-713e-4601-b391-dd9d71b6849f.pdf",
            "news_date": "2024-05-15 14:35:59",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Period Ended On December 31, 2023.",
            "news_body": "Please find attached herewith Unaudited Financial Results for period ended on December 31, 2023.",
            "news_id": "b20fbc34-ecb4-4945-a761-7f9f2cbf5ff1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e54794c0-9935-4803-b260-56b78e0b2288.pdf",
            "news_date": "2024-02-14 14:20:14",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended On 30.09.2023",
            "news_body": "Please find attached herewith Unaudited Financial Results for the period ended on September 30, 2023.",
            "news_id": "d629a683-0f16-42ba-ae8a-7a7610e79499",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cc5f77d-7e90-4c81-95f5-2b8c19e47b45.pdf",
            "news_date": "2023-11-10 12:25:20",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On June 30, 2023",
            "news_body": "Please find attached herewith the financial results for the period ended on June 30, 2023",
            "news_id": "84e16efd-d98a-4709-a1c8-84719ef9b9df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ea6f98-8f6a-443f-8a6a-04d3a24fa9f1.pdf",
            "news_date": "2023-08-14 13:28:53",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2023",
            "news_body": "We wish to inform you that the Board of Directors in their meeting held on May 26, 2023 have inter- alia decided and approved the following:Audited Financial Results:Pursuant to the Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''LODR Regulation'') the following documents are enclosed:  Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2023;  Auditors'' Reports thereon;  Statement of Assets and Liabilities (Standalone and Consolidated) as at March 31, 2023;  Cash Flow Statement (Standalone and Consolidated) for the year ended March 31, 2023;  Certificate for unmodified opinion.;",
            "news_id": "1f68bf84-e7f2-42f6-8ff9-58e82760ebd9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11a23791-23d0-46ef-8cf5-7102fa513475.pdf",
            "news_date": "2023-05-26 13:38:19",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Period Ended December 31, 2022",
            "news_body": "The Unaudited Standalone and Consolidated Financial Results for the quarter and nine months period ended December 31, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.",
            "news_id": "110fc40a-521c-4766-87fb-b91f062d1fee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=083c5ad0-ffca-4a49-baae-8c21e6ca5bda.pdf",
            "news_date": "2023-02-14 14:10:03",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For Half Year Ended On September 30, 2022",
            "news_body": "Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and captioned circular, please find enclosed the disclosure on Related Party Transactions for half year period from April 01, 2022 to September 30, 2022.",
            "news_id": "0c9fc587-b0d7-4700-b515-922ff6945d34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92a0b33-335b-4bf1-9a87-f4bf22a98171.pdf",
            "news_date": "2022-11-21 12:27:11",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results And Outcome Of Board Meeting",
            "news_body": "We wish to inform you that the Board of Directors in their meeting held on November 14, 2022, have inter-alia decided, approved:<BR> 1. and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and period ended on September 30, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon;<BR> 2. to amend the Code of Conduct for Prevention of Insider Trading to keep it in line with amended laws. The amended code has been updated on the website of the company at https://www.neclife.com/about-3-5;<BR> 3. to seek approval of shareholders through postal ballot process for:<BR> (i) Appointment of Mr. Puneet Sud as a Director of the company liable to retire by rotation (Ordinary Resolution);<BR> (ii) Appointment of Mr. Puneet Sud as a Whole time Director designated as a Director (Operations) of the company and to hold office for a period of two years (Special Resolution).<BR>",
            "news_id": "dc6373f4-a42f-44ea-90b1-987717168afe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84aabc50-2757-4bb9-823d-fd4161590d4b.pdf",
            "news_date": "2022-11-14 18:25:33",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended On June 30, 2022",
            "news_body": "Limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter ended on June 30, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon",
            "news_id": "51565763-c64c-4877-adce-5618ca9966af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715d9b9c-fe5a-42d0-a5ce-3a7a1a3e42d0.pdf",
            "news_date": "2022-08-13 13:44:55",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Period From October 01, 2021 To March 31, 2022.",
            "news_body": "Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and captioned circular, please find enclosed the disclosure on Related Party Transactions for half year period from October 01, 2021 to March 31, 2022.",
            "news_id": "891acdf7-a357-4bcc-a51b-92d31cece17a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75089c37-4622-43c9-ba68-e0c5b5436e16.pdf",
            "news_date": "2022-06-07 11:37:32",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results And Outcome Of Board Meeting",
            "news_body": "Audited Financial Results for the Financial Year 2021-22 and outcome of Board Meeting",
            "news_id": "0644d01f-dcb4-4a25-9295-3aa477fb8cc8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5764342c-4cc8-4000-b8cf-232ee110e408.pdf",
            "news_date": "2022-05-30 17:14:46",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Nine Months Ended On December 31, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and nine month ended on December 31, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.",
            "news_id": "89ea9e56-0a8d-479a-85ef-34a87ba97d00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f66d859f-a140-40ce-94da-8231712e070c.pdf",
            "news_date": "2022-02-14 16:35:13",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended On September 30, 2021.",
            "news_body": "Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the disclosure on Related Party Transactions of Nectar Lifesciences Limited on a consolidated basis for half year ended on September 30, 2021.",
            "news_id": "eaab5f5c-73bc-41d0-97d7-97f9a352ca8c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=149d0348-90df-4a36-8f29-f788b0016a8a.pdf",
            "news_date": "2021-12-06 13:53:33",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended On September 30, 2021.",
            "news_body": "The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and half year ended on September 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.",
            "news_id": "46c89a29-6896-48da-b3be-87cc1b41380c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8656ef1-2798-449a-ada0-92fb0b81bf8d.pdf",
            "news_date": "2021-11-13 17:10:27",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On June 30, 2021",
            "news_body": "Limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter ended on June 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.",
            "news_id": "0764192c-f431-45c0-a726-9f698d3ff567",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1018adeb-ef0a-4935-a8d7-7008dddbbbeb.pdf",
            "news_date": "2021-08-14 13:45:07",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the disclosure on Related Party Transactions of Nectar Lifesciences Limited on a consolidated basis for year ended on March 31, 2021.",
            "news_id": "0456063c-d0fa-4c56-b378-015ee0622dd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96b659e1-04c9-4e88-90ad-6e7209f37904.pdf",
            "news_date": "2021-07-26 12:45:19",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2021 And Outcome Of Board Meeting",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021 and Outcome of Board Meeting as per attached letter",
            "news_id": "8884df5c-edec-48f7-b6e6-3ae44efe2589",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f33589b7-a65a-4781-b7ce-b6988f3e54cc.pdf",
            "news_date": "2021-07-23 14:01:57",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NECLIFE",
            "disp": "Nectar Lifesciences",
            "bse_code": 532649,
            "isin": "INE023H01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended On December 31, 2020",
            "news_body": "The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter and nine months ended on December 31, 2020, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.",
            "news_id": "bdacec78-7b0e-4532-bd98-42847c0e687f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7274867c-43fa-497d-92a0-0e85291be3c9.pdf",
            "news_date": "2021-02-13 13:41:33",
            "seo": "nectar-lifesciences-ltd",
            "ltp": 13.64,
            "ch": -0.08999999999999986,
            "pch": -0.6554989075018198,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11930,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}